Evidence map›Paper›PMID 39503250›Full record

ArticleAllergy2025

Basophil activation test: How many basophils are enough?

Léonard Bezinge, Dominik Vogt, Anna Melone, Maximilien Lartigue, Cédric Giegelmann, Thomas Schuster, Michael Schneider, Michele Romano, Christian-Benedikt Gerhold, Michael A Gerspach and 1 more

Abstract readLetter
In one paragraph

Article in Allergy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Léonard BezingeBÜHLMANN Laboratories AG, Schönenbuch, Switzerland.ORCID https://orcid.org/0000-0002-9733-9697
Dominik VogtBÜHLMANN Laboratories AG, Schönenbuch, Switzerland.
Anna MeloneBÜHLMANN Laboratories AG, Schönenbuch, Switzerland.ORCID https://orcid.org/0000-0002-7520-1793
Maximilien LartigueBÜHLMANN Laboratories AG, Schönenbuch, Switzerland.
Cédric GiegelmannBÜHLMANN Laboratories AG, Schönenbuch, Switzerland.
Thomas SchusterBÜHLMANN Laboratories AG, Schönenbuch, Switzerland.
Michael SchneiderBÜHLMANN Laboratories AG, Schönenbuch, Switzerland.
Michele RomanoBÜHLMANN Laboratories AG, Schönenbuch, Switzerland.
Christian-Benedikt GerholdBÜHLMANN Laboratories AG, Schönenbuch, Switzerland.ORCID https://orcid.org/0000-0002-9982-9171
Michael A GerspachBÜHLMANN Laboratories AG, Schönenbuch, Switzerland.ORCID https://orcid.org/0000-0002-0128-4952
Christina BauerBÜHLMANN Laboratories AG, Schönenbuch, Switzerland.ORCID https://orcid.org/0000-0001-9511-2491

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39503250
PMCPMC11724242

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.